Abstract Prolactin (PRL) is a 23-kDa protein hormone that binds to a single-span membrane
receptor, a member of the cytokine receptor superfamily, and exerts its action via several …

Currently, there is no completely effective therapy available for metastatic
phaeochromocytomas (PCCs) and paragangliomas. In this study, we explore new molecular …

It is now apparent that regulation of blood vessel growth contributes to the classical actions
of hormones on development, growth, and reproduction. Endothelial cells are ideally …

Purpose Epidemiologic studies suggest that prolactin is associated with breast cancer risk in
older women. Because of limited prospective data, particularly in younger women, we …

Resistance to chemotherapy is a major complication in the treatment of advanced breast
cancer. Estrogens and prolactin (PRL) are implicated in the pathogenesis of breast cancer …

There is a large body of literature showing that prolactin (PRL) exerts growth-promoting
activities in breast cancer, and possibly in prostate cancer and prostate hyperplasia. In …

A number of epidemiologic studies of prolactin and breast cancer etiology have recently
become available. Retrospective case-control studies have suggested a modest positive or …

The prototypic pituitary hormone prolactin (PRL) exerts a wide variety of bioregulatory effects
in mammals and is also found in extrapituitary sites, including murine skin. Here, we show …

Objective A recent meta‐analysis showed that breast cancer probably is more common in
female patients with schizophrenia than in the general population (effect size= 1.25, P< …

Prolactin, a hormone involved in normal breast development and lactation, has been
hypothesized to be important in the etiology of breast cancer. This review summarizes in …